LIU DAVID R has a total of 17 patent applications. Its first patent ever was published in 2006. It filed its patents most often in United States. Its main competitors in its focus markets biotechnology, pharmaceuticals and foods and drinks are FEDERALNOE GOSUDARSTVENNOE BYUDZHETNOE UCHREZHDENIE NAUKI INST BIOORGANICHESKOJ KHIMII IM AKADEMIKOV, HILLEN WOLFGANG and MAX-DELBRÜCK-CENTRUM FÜR MOLEKULARE MEDIZIN IN DER HELMHOLTZ-GEMEINSCHAFT.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 17 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Foods and drinks | |
#4 | Organic fine chemistry | |
#5 | Machines |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Measuring microorganism processes | |
#5 | Enzymes | |
#6 | Medical preparations | |
#7 | Unspecified technologies | |
#8 | Fermentation | |
#9 | Combinatorial chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Liu David R | 17 |
#2 | Calderone Christopher T | 3 |
#3 | Rosenbaum Daniel M | 3 |
#4 | Gartner Zev | 2 |
#5 | Lawrence Michael S | 2 |
#6 | Rozenman Mary M | 2 |
#7 | Phillips Kevin John | 2 |
#8 | Kanan Matthew W | 2 |
#9 | Kleiner Ralph E | 2 |
#10 | Brudno Yevgeny | 1 |
Publication | Filing date | Title |
---|---|---|
US2013345064A1 | Continuous directed evolution | |
US2013178429A1 | Macrocyclic kinase inhibitors and uses thereof | |
US2013225426A1 | Reactivity-dependent and interaction-dependent PCR | |
US2009263851A1 | In vivo selection system for enzyme activity | |
US2010209994A1 | Protein surface remodeling | |
US2008318807A1 | Iterated branching reaction pathways via nucleic acid-mediated chemistry | |
US2009203530A1 | Polymer evolution via templated synthesis |